Each year MDA funds about 250 research grants aimed at developing treatments for the more than 40 neuromuscular diseases in our program. It’s a huge investment — the largest of any nonprofit voluntary health agency dedicated to fighting neuromuscular disease. However, MDA does not simply “throw money at science.” Biomedical research, by its very nature, is costly and carries some risk of failure. Only the best-conceived, most therapeutically relevant projects and most promising researchers — as judged by the world’s leading biomedical experts — receive MDA funding. The process of awarding an MDA grant is objective, informed, rigorous and ethical.
MDA recognizes that research at every level, from fundamental research into muscle biology through clinical trials of new therapeutics, contributes to the development of treatments for our diseases. MDA recognizes that there are different challenges at each stage of research, so it has different types of grants and different procedures in place to maximize the effectiveness of our review process.
MDA also supports the training of new researchers, and it recognizes the importance of getting brilliant young scientists and physicians into the field of neuromuscular disease research.
How does MDA select what to fund? Visit MDA's Funding Process chart to learn more.
Muscular Dystrophy Association — USA
222 S. Riverside Plaza, Suite 1500
Chicago, Illinois 60606
The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization.
©2014, Muscular Dystrophy Association Inc. All rights reserved.